Retinoblastoma

Singapore Medical Journal

Volumn 53, Issue 2, 2012, Pages 128-136

  Mehta, M ^a   Sethi, S ^a   Pushker, N ^a   Kashyap, S ^b   Sen, S ^b   Bajaj, M S ^a   Ghose, S ^a  

^a Paediatric Ophthalmology and Oncology Services   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chemoreduction; Intraocular tumour; Leukocoria; Retinoblastoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; BRACHYTHERAPY; BUPHTHALMOS; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; ECHOGRAPHY; ENUCLEATION; EXOPHTHALMOS; EXTERNAL BEAM RADIOTHERAPY; EYE EXAMINATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; LASER COAGULATION; LEUKOKORIA; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; PROGNOSIS; RETINA; RETINOBLASTOMA; STRABISMUS; TRANSPUPILLARY THERMOTHERAPY; VISUAL IMPAIRMENT;

CHILD; HUMANS; RETINA; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 84857148494     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Abramson DH, Schefler AC. Update on retinoblastoma. Retina 2004; 24: 828-48.
2. Atchaneeyasakul L, Murphree AL. Retinoblastoma. In: Schachat AP, Ryan SJ, Murphy RP, eds. Retina, 3rd edn (volume-1). Missouri: Mosby; 2001:513-70.
3. Shields JA, Shields CL, Parsons HM. Dif ferential diagnosis of retinoblastoma. Retina 1991; 11:232-43.
4. Balasubramanya R, Pushker N, Bajaj MS, et al. Atypical presentations of retinoblastoma. J Pediatr Opthalmol Strabismus 2004; 41:18-24.
5. Van Esch H, Aerssens P, Fryns JP. The importance of excluding 13q deletion mosaicism in the diagnosis of retinoblastoma associated with dysmorphic features. Genet Couns 2005; 16:91-3.
6. Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 2006; 17:228-34.
7. Sterns GK, Coleman DJ, Ellsworth RM. The ultrasonographic characteristics of retinoblastoma. Am J Ophthalmol 1974; 78:606-11.
8. Kaufman LM, Mafee MF, Song CD. Retinoblastoma and simulating lesions. Role of CT, MR imaging and use of Gd-DTPA contrast enhancement. Radiol Clin North Am 1998; 36:1101-17.
9. Schueler AO, Hosten N, Bechrakis NE, et al. High resolution magnetic resonance imaging of retinoblastoma. Br J Ophthalmol 2003; 87:330-5.
10. Shields JA, Shields CL. Management of retinoblastoma. In: Intraocular tumors: an atlas and textbook, 2nd edn. Philadelphia: Lippincott Williams and Wilkins; 2008: 334-51.
11. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000; 18:12-7.
12. Shields JA, Parsons H, Shields CL, Giblin ME. The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol 1989; 108:260-4.
13. Shields CL, Santos C, Diniz W, et al. Thermotherapy for retinoblastoma. Arch Ophthalmol 1999; 117:885-93.
14. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for retinoblastoma: long term control and treatment complications in 208 tumors. Ophthalmology 2001; 108:2116-21.
15. Shields JA, Shields CL, De Potter P. Enucleation technique for children with retinoblastoma. J Pediatr Ophthalmol Strabismus 1992; 29:213-5.
16. th edn. Philadelphia: WB Saunders; 1996: 1340-75.
17. Pradhan MA, Ng Y, Strickland A, et al. Role of genetic testing in retinoblastoma management at a tertiary referral centre. Clin Experiment Ophthalmol 2010; 38:231-6.
18. Dunkel IJ, Khakoo Y, Kernan NA, et al. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. Pediatr Blood Cancer 2010; 55:55-9.